Free mobile app delivers breach intelligence, compliance tools, and shared threat awareness for independent healthcare ...

KEIGHLEY, UK - March 16, 2026 - PRESSADVANTAGE - Private patients in Keighley who are experiencing extensive tooth loss ...

HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home ...

Lead program VMT-α-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as ...

Lead program VMT-a-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reporte ...

America’s hospitals and health systems remain the backbone of the U.S. health care system, while today’s care is more ...

Like fit notes, the issuing of autism referrals is fast becoming a formality for GPs, rather than what it should be - an ...

Early clinical proof-of-concept for WEE1 inhibitor APR-1051 in the ongoing ACESOT-1051 trial with two partial responders at first scan in endometrial cancer patients with PPP2R1A mutationClinical team ...

Europe's AI regulatory push is moving fast, but speed without coherence risks undermining the very innovation it seeks to ...

Full body scans, IV drips, at-home hyperbaric chambers, cryotherapy - the business of living longer has never been bigger in ...

Sciatica is becoming increasingly common, but it is also increasingly understood. Evidence from top ranked universities in ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients ...